Egypt’s Minister of Health and Population Khaled Abdel Ghaffar has stressed the importance of expanding “Egyptian-Indian” investments, mainly in the field of manufacturing vaccines and medicines.

This came during his speech in a press conference on Saturday, at the headquarters of the Holding Company for Biological Products and Vaccines (Vacsera), to launch the first production line of the “Hepatitis B and Pentavalent” vaccines, with a production capacity of 100 million doses annually, in cooperation with the Serum Institute of India.